GreenLight Biosciences Holdings (GRNA) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Medford, MA, 美国. 现任CEO为 Andrey Juan Zarur.
GRNA 拥有 IPO日期为 2022-02-03, 280 名全职员工, 在 NASDAQ Global Market, 市值为 $45.43M.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
